Theseus Pharma Lays Off Staff, Explores Options Months After Toxicity Scuttles Lead Drug
Theseus Pharmaceuticals discontinued its former lead program in July following the report of dose-limiting toxicities in two patients. Though Theseus has other assets in its pipeline, it has decided to explore strategic alternatives with the goal of “maximizing shareholder value.”
